Brian Joseph Lynch Madrigal Pharmaceuticals, Inc. (MDGL) insider trading activity

Brian Joseph Lynch is SVP and General Counsel of MADRIGAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 17,691 shares of MDGL, which is worth approximately $4.89 Million. The most recent transaction as insider was on Jan 23, 2024, when has been sold 3,639 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.7K

0% 3M change

17.93% 12M change

Total Value Held $4.89 Million

Brian Joseph Lynch Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 23 2024	BUY Grant, award, or other acquisition	-	3,639 Added 17.06%	17,691 Common Stock
Jan 16 2024	SELL Payment of exercise price or tax liability	$231,480 $243.92 p/Share	949 Reduced 6.33%	14,052 Common Stock
Dec 05 2023	SELL Open market or private sale	$227,330 $227.33 p/Share	1,000 Reduced 6.25%	15,001 Common Stock
Dec 05 2023	BUY Exercise of conversion of derivative security	$87,090 $87.09 p/Share	1,000 Added 5.88%	16,001 Common Stock
Dec 04 2023	SELL Open market or private sale	$393,408 $218.56 p/Share	1,800 Reduced 10.71%	15,001 Common Stock
Dec 04 2023	BUY Exercise of conversion of derivative security	$144,756 $80.42 p/Share	1,800 Added 9.68%	16,801 Common Stock
Nov 30 2023	SELL Open market or private sale	$613,740 $204.58 p/Share	3,000 Reduced 16.67%	15,001 Common Stock

Nov 30 2023	BUY Exercise of conversion of derivative security	$221,250 $73.75 p/Share	3,000 Added 14.29%	18,001 Common Stock
Nov 29 2023	SELL Open market or private sale	$795,680 $198.92 p/Share	4,000 Reduced 21.05%	15,001 Common Stock
Nov 29 2023	BUY Exercise of conversion of derivative security	$295,000 $73.75 p/Share	4,000 Added 17.39%	19,001 Common Stock
Jan 16 2023	BUY Grant, award, or other acquisition	-	15,001 Added 50.0%	15,001 Common Stock
Jan 03 2023	SELL Open market or private sale	$3,681,340 $283.18 p/Share	13,000 Reduced 100.0%	0 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	$1,193,270 $91.79 p/Share	13,000 Added 50.0%	13,000 Common Stock
Dec 23 2022	SELL Open market or private sale	$1,926,959 $275.28 p/Share	7,000 Reduced 100.0%	0 Common Stock
Dec 23 2022	BUY Exercise of conversion of derivative security	$642,530 $91.79 p/Share	7,000 Added 50.0%	7,000 Common Stock

BJL

Brian Joseph Lynch

SVP and General Counsel

West Conshohocken, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDGL shares.

Notify only if

Value

Insider Trading

Get notified when an Madrigal Pharmaceuticals, Inc. insider buys or sells MDGL shares.

Notify only if

Operation

Value

Type

News

Receive news related to MADRIGAL PHARMACEUTICALS, INC.

Track Activities on MDGL

Account